Polymerase Chain Reaction Market Analysis

  • Report ID: 2327
  • Published Date: Aug 22, 2025
  • Report Format: PDF, PPT

Polymerase Chain Reaction Market Segmentation:

Application Segment Analysis

In the application segment, clinical diagnostics lead the segment and are poised to hold the share value of 44.5% by 2035. The evidence from the CDC depicts that PCR remains essential to diagnose pathogens like SARS-CoV-2, influenza, and tuberculosis. The use of PCR-related diagnostics in oncology surges the demand further. Additionally, the rise in funding by NIH for research in molecular diagnostics accelerates the technology integration in hospital workflows. This makes clinical diagnostics the most prevalent application in 2035.

Technology Segment Analysis

Under the technology segment, quantitative PCR dominates the segment and holds a considerable share value by 2035. Quantitative PCR is driven by its sensitivity, accuracy, and real-time monitoring capabilities. The FDA evidence depicts that qPCR is a standard test for viral load monitoring (HIV, Hepatitis B/C) and cancer biomarker detection. This test is widely used in food safety, clinical labs and genetic research. As per the NCI, qPCR is the vital test for translational cancer research, providing information on tumor genetics and therapy response. The World Economic Forum report in June 2021 depicts that more than 1.0 billion tests are performed to check COVID-19 using qPCR. Growing reliance on qPCR in personalized medicine and public health surveillance supports its continued market leadership.

Type Segment Analysis

The real-time PCR (qPCR) leads the type segment and is expected to hold the highest revenue share by 2035. The segment is dominated by its extensive uptake in clinical diagnostics, infectious disease surveillance, and oncology research. Based on the CDC report, the qPCR is the key for analyzing pathogen detection and has screened millions of SARS-CoV-2 tests over the past four years. This points out the scalability and precision of real-time qPCR test. Further, the National Institutes of Health (NIH) report in September 2024 indicated that NIH was awarded $27million to expand genomics research where qPCR plays a central role.

Our in-depth analysis of the global polymerase chain reaction market includes the following segments: 

Segment

Subsegment

Type

  • Real-Time PCR (qPCR)
  • Clinical Diagnostics
  • Forensic Science
  • Research
  • Industrial
  • Conventional PCR
  • Clinical Diagnostics
  • Forensic Science
  • Research
  • Industrial
  • Digital PCR
  • Clinical Diagnostics
  • Research
  • Industrial

Product

  • Instruments
  • Reagents & Consumables
  • Software & Services

Application

  • Clinical Diagnostics
  • Forensic Science
  • Research
  • Industrial

Technology

  • Quantitative PCR
  • Digital PCR
  • Conventional PCR

End user

  • Hospitals & Diagnostic Labs
  • Research & Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Forensic Laboratories
  • Industrial Laboratories

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of polymerase chain reaction is evaluated at USD 19.4 billion.

Polymerase Chain Reaction Market size was over USD 18.3 billion in 2025 and is poised to exceed USD 33.9 billion by 2035, growing at over 6.7% CAGR during the forecast period i.e., between 2026-2035.

North America industry is expected to hold largest revenue share by 2035, as a result of growing advancements in the healthcare industry in the region.

The major players in the market are Abbott Laboratories, Becton, Dickinson and Company, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, bioMérieux, Siemens Healthcare Private Limited, Merck KGaA, Thermo Fisher Scientific Inc., PerkinElmer Inc., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos